Brazil moves to reform device group registration with new traceability & labelling rules
This article was originally published in Clinica
Executive Summary
Brazil is reforming the system for registering medical device "product groupings". Draft regulations issued for public consultation seek to address the "need to establish new criteria on how medical devices are organised and grouped" for the purpose of registration with healthcare surveillance agency Anvisa - or their exemption from this; they also, crucially, redefine the concepts of product families, kits/sets, systems and stand-alone products.
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.